اپی‌نفرین (Epinephrine)
۵۸ محصول ثبت‌شده بدون نسخه NDAANDA
خلاصهٔ ثبت FDA
- فرم‌های دارویی
- SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS · SOLUTION;INTRAVENOUS
- دوزهای ثبت‌شده
- 1MG/ML (1MG/ML) · 30MG/30ML (1MG/ML) · 0.3MG/DELIVERY · 0.15MG/DELIVERY
- شرکت‌های دارنده
- PH HEALTH · GLAND · BPI LABS · VIATRIS
- پروندهٔ رسمی
- 205029
محصولات ثبت‌شده (۵۸ مورد)
| نام محصول | فرم | دوز | شرکت | نوع | وضعیت | پرونده |
|---|---|---|---|---|---|---|
| SUS-PHRINE SULFITE FREE | INJECTABLE;INJECTION | 5MG/ML | FOREST LABS | NDA | متوقف‌شده | 007942 |
| SUS-PHRINE SULFITE FREE | INJECTABLE;INJECTION | 1.5MG/AMP | FOREST LABS | NDA | متوقف‌شده | 007942 |
| PRIMATENE MIST | AEROSOL, METERED;INHALATION | 0.2MG/INH | WYETH CONS | NDA | متوقف‌شده | 016126 |
| BRONKAID MIST | AEROSOL, METERED;INHALATION | 0.25MG/INH | STERLING | NDA | متوقف‌شده | 016803 |
| EPIPEN | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 0.3MG/DELIVERY | VIATRIS | NDA | نسخه‌ای | 019430 |
| EPIPEN JR. | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 0.15MG/DELIVERY | VIATRIS | NDA | نسخه‌ای | 019430 |
| EPIPEN E Z PEN | INJECTABLE;INTRAMUSCULAR | 0.3MG/DELIVERY | VIATRIS | NDA | متوقف‌شده | 019430 |
| EPI E Z PEN JR | INJECTABLE;INTRAMUSCULAR | 0.15MG/DELIVERY | VIATRIS | NDA | متوقف‌شده | 019430 |
| TWINJECT | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.3MG/DELIVERY | IMPAX | NDA | متوقف‌شده | 020800 |
| TWINJECT | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.15MG/DELIVERY | IMPAX | NDA | متوقف‌شده | 020800 |
| ADRENACLICK | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.15MG/DELIVERY | IMPAX | NDA | نسخه‌ای | 020800 |
| ADRENACLICK | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.3MG/DELIVERY | IMPAX | NDA | نسخه‌ای | 020800 |
| EPINEPHRINE | AEROSOL, METERED;INHALATION | 0.2MG/INH | ARMSTRONG PHARMS | ANDA | متوقف‌شده | 087907 |
| EPINEPHRINE (AUTOINJECTOR) | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 0.3MG/DELIVERY | TEVA PHARMS USA | ANDA | نسخه‌ای | 090589 |
| EPINEPHRINE (AUTOINJECTOR) | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 0.15MG/DELIVERY | TEVA PHARMS USA | ANDA | نسخه‌ای | 090589 |
| AUVI-Q | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.3MG/DELIVERY | KALEO INC | NDA | نسخه‌ای | 201739 |
| AUVI-Q | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.15MG/DELIVERY | KALEO INC | NDA | نسخه‌ای | 201739 |
| AUVI-Q | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | EQ 0.1MG/DELIVERY | KALEO INC | NDA | نسخه‌ای | 201739 |
| ADRENALIN | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | PH HEALTH | NDA | نسخه‌ای | 204200 |
| ADRENALIN | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | PH HEALTH | NDA | نسخه‌ای | 204640 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 1MG/ML (1MG/ML) | BPI LABS | NDA | نسخه‌ای | 205029 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 10MG/10ML (1MG/ML) | BPI LABS | NDA | نسخه‌ای | 205029 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BPI LABS | NDA | متوقف‌شده | 205029 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 30MG/30ML (1MG/ML) | BPI LABS | NDA | نسخه‌ای | 205029 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1MG/ML (1MG/ML) | BPI LABS | NDA | نسخه‌ای | 205029 |
| PRIMATENE MIST | AEROSOL, METERED;INHALATION | 0.125MG/INH | ARMSTRONG PHARMS | NDA | بدون نسخه | 205920 |
| SYMJEPI | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.3MG/0.3ML (0.3MG/0.3ML) | ADAMIS PHARMS CORP | NDA | نسخه‌ای | 207534 |
| SYMJEPI | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.15MG/0.3ML (0.15MG/0.3ML) | ADAMIS PHARMS CORP | NDA | متوقف‌شده | 207534 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | AM REGENT | ANDA | متوقف‌شده | 207568 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | HOSPIRA INC | ANDA | تأیید مشروط | 208908 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS | 1MG/10ML (0.1MG/ML) | HOSPIRA | NDA | متوقف‌شده | 209359 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS | 1MG/10ML (0.1MG/ML) | INTL MEDICATION SYS | NDA | نسخه‌ای | 211363 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | INTL MEDICATION SYS | ANDA | نسخه‌ای | 211880 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 1MG/ML (1MG/ML) | FRESENIUS KABI USA | ANDA | نسخه‌ای | 213708 |
| NEFFY | SPRAY;NASAL | 2MG/SPRAY | ARS PHARMS OPERATION | NDA | نسخه‌ای | 214697 |
| NEFFY | SPRAY;NASAL | 1MG/SPRAY | ARS PHARMS OPERATION | NDA | نسخه‌ای | 214697 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 30MG/30ML (1MG/ML) | FRESENIUS KABI USA | NDA | نسخه‌ای | 215425 |
| ADRENALIN | SOLUTION;INTRAVENOUS | 2MG/250ML (8MCG/ML) | PH HEALTH | NDA | نسخه‌ای | 215875 |
| ADRENALIN | SOLUTION;INTRAVENOUS | 4MG/250ML (16MCG/ML) | PH HEALTH | NDA | نسخه‌ای | 215875 |
| ADRENALIN | SOLUTION;INTRAVENOUS | 5MG/250ML (20MCG/ML) | PH HEALTH | NDA | نسخه‌ای | 215875 |
| ADRENALIN | SOLUTION;INTRAVENOUS | 8MG/250ML (32MCG/ML) | PH HEALTH | NDA | نسخه‌ای | 215875 |
| ADRENALIN | SOLUTION;INTRAVENOUS | 10MG/250ML (40MCG/ML) | PH HEALTH | NDA | نسخه‌ای | 215875 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | AM REGENT | ANDA | نسخه‌ای | 217192 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1MG/ML (1MG/ML) | DEVA HLDING | ANDA | نسخه‌ای | 217426 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | AMNEAL | ANDA | نسخه‌ای | 217485 |
| EPINEPHRINE | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 1MG/ML (1MG/ML) | GLAND | ANDA | نسخه‌ای | 218144 |
| EPINEPHRINE | INJECTION;SOLUTION,CONCENTRATE | 10MG/10ML | GLAND | ANDA | تأیید مشروط | 218144 |
| EPINEPHRINE | INJECTION;SOLUTION,CONCENTRATE | 30MG/30ML | GLAND | ANDA | تأیید مشروط | 218144 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | AMNEAL | ANDA | نسخه‌ای | 218208 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 10MG/10ML (1MG/ML) | GLAND | ANDA | نسخه‌ای | 219239 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 30MG/30ML (1MG/ML) | GLAND | ANDA | نسخه‌ای | 219239 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1MG/ML (1MG/ML) | GLAND | ANDA | نسخه‌ای | 219239 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | ZYDUS PHARMS | ANDA | نسخه‌ای | 219832 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) | GLAND | ANDA | نسخه‌ای | 220400 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1MG/ML (1MG/ML) | HIKMA | ANDA | نسخه‌ای | 220562 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1MG/ML (1MG/ML) | BAXTER HLTHCARE CORP | NDA | نسخه‌ای | 220626 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 30MG/30ML (1MG/ML) | BAXTER HLTHCARE CORP | NDA | نسخه‌ای | 220626 |
| EPINEPHRINE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | APOTEX | ANDA | نسخه‌ای | 220657 |
این پرونده از کجا می‌آید؟
داده‌ها از فایل‌های رسمی Drugs@FDA data files (Products، Applications و MarketingStatus) گرفته شده‌اند. هر ردیف جدول یک محصول ثبت‌شده با همان مادهٔ مؤثره است؛ شمارهٔ پرونده به صفحهٔ رسمی FDA لینک دارد. وضعیت «متوقف‌شده» یعنی محصول دیگر توزیع نمی‌شود.
خبر دارو و سلامت را
از دست ندهید
روزی چند گزارش کوتاه، بدون تبلیغ و بدون اسپم.